Objective: The natriuretic peptides (NPs), atrial (ANP), B-type (BNP), and C-type (CNP) natriuretic peptides as well as their respective receptor-guanylyl cyclases (GC-A for ANP and BNP, and GC-B for CNP) are expressed in the heart. However, the local role of NPs in the regulation of cardiac contractility and the mutual interactions of NPs remain controversial. In the present study we evaluated the effects of ANP and CNP on cardiac function of wild-type (GC-A 1 / 1) and GC-A-deficient (GC-A 2 / 2) mice. Methods: The effects of NPs and their molecular mechanisms were assessed in the isolated perfused mouse working heart preparation. Results: In GC-A 1 / 1 hearts, CNP exerted a biphasic action: an immediate increase in inotropy and lusitropy, followed by a slowly developing negative inotropic effect. These effects were mimicked by the cGMP-analogue, 8-pCPT-cGMP. In contrast, ANP did not affect cardiac function. In GC-A 2 / 2 hearts, the immediate contractile responses to CNP and 8-pCPT-cGMP were significantly enhanced. CNP increased cardiac cGMP levels and stimulated phospholamban (PLB) phosphorylation; the effect on PLB, but not cGMP, was enhanced in GC-A 2 / 2 hearts. In addition, cardiac expression of cGMP-dependent protein kinase (cGK I) was significantly increased in GC-A 2 / 2 mice. Conclusion: CNP exerts a biphasic, initially positive inotropic and lusitropic, then negative inotropic effect in isolated working mouse hearts. A putative mechanism contributing to the immediate contractile responses is cGMP/ cGK I-dependent phosphorylation of PLB and 21 subsequent activation of the sarcoplasmic reticulum Ca -pump. ANP has no direct effects on cardiac contractility but chronic absence of its receptor, GC-A, results in increased responsiveness to CNP.
Introduction
. Activation of these receptors results in an increase of intracellular cGMP levels which in turn mediates cellular The natriuretic peptide (NP) family contains at least responses leading to vasodilatation and increased natthree members: atrial (ANP), B-type (BNP), and C-type riuresis and diuresis [1] . Accordingly, deletion of GC-A in (CNP) natriuretic peptides. ANP and BNP are mainly mice (GC-A 2 / 2) prevents the vasorelaxant effects of released from the heart to act as circulating hormones ANP and BNP and leads to chronic hypertension and (endocrine system), whereas CNP is an endothelial peptide cardiac hypertrophy [2, 3] . In contrast, the hypotensive and presumably with local actions (paracrine system). The vasorelaxant effects of CNP are not changed in GC-Aeffects of these peptides are attributed to the activation of deficient mice [4] . two specific receptor-guanylyl cyclases (GC): GC-A (with A third receptor which also triggers effects of NPs, the highest affinity for ANP and BNP) and GC-B (for CNP) C-receptor (NPR-C), has a similar affinity for all three peptides. It is not linked to a guanylyl cyclase domain and is thought to function as a clearance receptor which mediates the cellular internalization of NPs [5] . Recently it and Use of Laboratory Animals published by the US was demonstrated that the short cytoplasmic region of National Institutes of Health (NIH Publication No. 85-23, NPR-C activates GTP-binding proteins to inhibit adenylyl revised 1996) and was approved by the local animal care cyclase, supporting a signal-transducing role for this committee. receptor [6] . However, inactivation of the gene for NPR-C in mice indicated that at least within the cardiovascular 2.2. Measurement of cardiac contractile parameters in system its main function is to remove NPs from the isolated work-performing heart preparations circulation, thereby modulating their local physiological effects [7] .
Analysis of cardiac function was as described previously All components of the NP system, the peptides and their [16, 17] . In brief, isolated hearts from GC-A 1 / 1 and receptors, are expressed within the heart. ANP and BNP GC-A 2 / 2 mice were perfused with Krebs-Henseleit are secreted from cardiomyocytes and CNP is synthesized (KH) buffer through the pulmonary vein and left atrium, in and secreted by the coronary endothelium [8] . GC-A, an anterograde, fluid-ejecting mode. Fluid ejected from an GC-B and NPR-C are located on cardiac myocytes and aortic cannula against a hydrostatic fluid column set at a fibroblasts as well as within coronary vessels [9] . It is height to yield a mean aortic pressure (afterload) of 50 postulated that besides their endocrine actions on distant mmHg. Venous return (preload) was measured using a tissues, the NPs modulate growth and contractility of flowmeter (Transonic Systems Inc., Ithaca, USA) and cardiomyocytes and proliferation of cardiac fibroblasts in adjusted to (30 ml / min / g estimated dry heart weight. For an autocrine / paracrine way [10, 11] . However, direct efthis purpose, wet heart weights were directly measured fects of NPs on cardiac contractility remain controversial.
prior to perfusion and dry weight was estimated on the For CNP, 'acute' positive inotropic effects on isolated basis of a wet-to-dry-weight curve plotted from previous canine atrial and ventricular preparations have been reobservations in 15 hearts. Coronary flow (calculated as the ported [12, 13] . In isolated rat papillary muscles, CNP difference between preload and aortic flow), heart rate, displays a positive lusitropic and delayed negative inoaortic pressure and left intraventricular pressure were tropic action [14] . The effects of ANP on cardiac contraccontinuously monitored, and the first derivatives of left tility are even less clear. While some studies showed that intraventricular pressure, 1 dP/dt and 2 dP/dt (in ANP decreased contractility in isolated cardiomyocytes mmHg / s), time to peak pressure and time to relaxation (in [15] , other studies saw no effect of the peptide on cardiacm s) were calculated (A Mon 2.1 program, Ingenieurburo mechanical functions [13, 14] .J ackel, Hanau, Germany). These parameters have been To further characterize how NPs modulate cardiac shown to be good indices of cardiac contractility and function and to determine their mutual interactions, we relaxation in this experimental model [16] [17] [18] . studied responses to ANP and CNP in an in vitro isolated work-performing mouse heart preparation. In particular, 2.3. Experimental protocols CNP was found to have initial positive inotropic and lusitropic effects, followed by a delayed negative inotropic After a 20-min equilibration period, the test agents were action. CNP/ cGMP activation of cGMP-dependent protein infused continuously for the duration of the experiment via kinase I (cGK I) and phospholamban (PLB) phosphorylathe coronary arteries. Control hearts of each genotype were tion may lead to the early CNP contractile responses by 21 infused with KH-buffer for 5 min or 60 min (n55). facilitating pumping of Ca into the sarcoplasmic reticulum. In GC-A deficient (GC-A 2 / 2) mice, both CNP (a) CNP was infused into GC-A 1 / 1 and GC-A 2 / 2 effects on early cardiac contractility, as well as cGK I hearts for 60 min (100 nM CNP; n56) and for 5 min expression and PLB phosphorylation are enhanced.
(1 nM CNP, n53; 10 and 100 nM CNP, n57). [2] . Male GC-A 2 / 2 mice by ANP [20] was infused into GC-A 1 / 1 hearts at and their nontransgenic (GC-A 1 / 1) littermates, 6 300 nM. After testing for intrinsic activity (infused months old, were used. Genotypes were confirmed by alone for 15 min), A71915 was combined with CNP PCR. Blood pressure measurements were made in con-(100 nM) and infused for an additional 5 min (n55). scious mice using a tail cuff method (Softron, Tokyo) [4] .
(d) ANP (100 nM) was infused into GC-A 1 / 1 hearts The investigation conforms with the Guide for the Care for 30 min (n56).
(e) 8-pCPT-cGMP, a membrane permeable cGMP ana-2.6. Western blot analysis logue, was infused into GC-A 1 / 1 and GC-A 2 / 2 hearts at 100 mM for 10 min (n56) and 60 min
To determine the expression level of protein kinases, of (n52).
phospholamban (PLB), and the effect of CNP and 8-pCPT-cGMP on PLB phosphorylation, frozen ventricles from hearts infused with these agents or with KH buffer To study the effect of NPs on intracellular messenger (controls) were homogenized and analyzed by Western blot systems, the isolated working hearts were quickly stopped as described [23] [24] [25] . Antibodies used to study protein by shock freezing both ventricles in liquid nitrogen.
kinase expression were against cGMP-dependent protein Untreated hearts infused with KH-buffer for the same time kinase I (cGK I; diluted 1:3000) [23] and against the periods were used as controls. The frozen ventricles were catalytic subunit of cAMP-dependent protein kinase (cAK, then extracted for assay of cyclic nucleotide contents and diluted 1:2000) [24] ; detection was with an ECL system for Western blot analysis.
(Amersham-Pharmacia, Freiburg, Germany). To study PLB expression and phosphorylation, primary antibodies 2.4. Determination of intracellular cGMP and cAMP used were against total PLB (PLB A-1 antibody) and contents against PLB phosphorylated at serine-16 (PLB-PS-16) (Fluorescience Ltd., Leeds, UK) [25, 26] . Secondary de- (both from ICN Biomedicals, Eschwege, Germany). The were dried in a speed vacuum concentrator, resuspended in signal obtained with the phosphorylation site-specific sodium acetate buffer (50 mM, pH 6.0) and acetylated, and antibody (PLB-PS-16) was normalized to total PLB dethen cGMP and cAMP contents were quantified by respectermined using the PLB A-1 antibody [25] . tive radioimmunoassays (Ref. [21] for cGMP; cAMP-RIA, Amersham, Freiburg, Germany). The pellets of the ethanol 2.7. Agents extracts were used for determination of protein content.
Rat ANP and human CNP were obtained from Cal-
Quantitative real-time RT-PCR analysis of GC-B
biochem-Novabiochem (Bad Soden, Germany); 8-paraand NPR-C mRNA expression chlorophenylthio-cGMP (8-pCPT-cGMP) from Biolog (Bremen, Germany); A71915 and cANP from Bach- (4 -23) Total RNA from control hearts perfused with KH-buffer em California Inc. (Torrance, CA, USA). All other agents was isolated by RNeasy Kit (Qiagen, Hilden, Germany)
were from Sigma (Deisenhofen, Germany). and 1 mg of RNA was reverse transcribed with random primers (Clontech, Heidelberg, Germany). A quantitative 2.8. Statistics analysis of GC-B and NPR-C mRNA expression was performed by RT-PCR using the LightCyclerE Detection
Results are presented as the means6S.E.M. and, where System (Roche, Mannheim, Germany) as described previindicated, values were normalized by expression as % of ously [22] . The system uses two fluorogenic probes to baseline. Student's t-test was used for comparison of data, generate sequence-specific fluorescent signals during PCR.
except that the serial changes in cardiac function measured The following primers and fluorescent probes were used after peptide infusions within each study protocol were (all designed and synthesized by Tib Molbiol, Berlin, tested with a repeated-measures ANOVA followed by Germany): for GC-B: forward primer, 59-CCAGAACACBonferroni and Student-Newman-Keuls post hoc test for AACCTGAGCTATGC; reverse primer, 59-GGGCCGCAGmultiple comparisons (GraphPad InStat software). Results ATATACACAATGC (PCR product 599 bp), detection were considered statistically significant in all analyses at probe: 59-LC Red640-CCCTGAGCAAGCCACCCACTT-P,0.05. CATC-p, anchor probe: 59-CCAGGTGTATGCCCGAGA-GCCAGGT-fluorescein; for NPR-C: forward primer, 59-TCTGCCTACAATTTCGACGAG; reverse primer, 59-CACAGAGAAGTCCCCATACCG (PCR product 560 bp), 3. Results detection probe: 59-LC Red640-GTCACCCTACTGAGGA-CCGTGAAAC-p, anchor probe: 59-AAACAAGCA-3.1. Baseline cardiovascular parameters TACTCGTCCCTCCAAC-fluorescein. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used for normaliIn agreement with previous observations [2] [3] [4] , GC-A zation [22] . Preliminary experiments showed that GAPDH 2 / 2 mice had markedly higher systolic (14663. as maximal systolic pressure, was observed. The time of relaxation started to increase after 5 min, almost returning increased heart weights and heart / body weight ratios as to baseline values after 60 min of treatment with CNP. compared to wild-type mice (Table 1 ). Table 1 also shows Heart rate did not significantly change during 60 min of the contractile parameters of isolated hearts from GC-A infusion with CNP. Coronary flow progressively increased 1 / 1 and GC-A 2 / 2 mice in the work-performing to¯12865% of pretreatment values within 15 min (*P, preparation under basal conditions. The time to relaxation 0.05 vs. baseline) and then remained stable for the rest of of the GC-A 2 / 2 hearts was significantly prolonged as the CNP-infusion time. compared to GC-A 1 / 1; no other basal parameters of
The biphasic effects of CNP on cardiac contractility were also observed in isolated hearts from GC-A 2 / 2 on GC-A 1 / 1 hearts and additionally did not signifimice (Fig. 1) . Remarkably, the initial changes (namely the cantly alter the immediate effects of CNP on contractility positive inotropic and lusitropic actions) were significantly and coronary flow in GC-A 1 / 1 hearts (Table 2) . greater as compared to GC-A 1 / 1 hearts. The CNPinduced increase in coronary flow (to 12567% of baseline) 3.4. Effects of 8-pCPT-cGMP on cardiac contractile was comparable to GC-A 1 / 1 hearts (*P,0.05 vs. parameters baseline). Heart rates did not significantly change during CNP treatment in GC-A 2 / 2 hearts either.
8-pCPT-cGMP, a membrane-permeable, phosphodiesControl GC-A 1 / 1 and GC-A 2 / 2 hearts infused terase-resistant, selective activator of cGMP-dependent with vehicle (KH buffer) revealed no significant changes in kinases [27], mimicked the immediate (Fig. 3 ) and late contractile function over a 60-min observation time, in-(see below) effects of CNP on cardiac contractility and dicating that the delayed decrease in cardiac inotropy relaxation. As observed for CNP, the immediate inotropic observed during infusion of CNP does not simply reflect a and lusitropic responses to 8-pCPT-cGMP (100 mM), were spontaneous deterioration of heart function but is indeed more pronounced in GC-A 2 / 2 compared to GC-A related to the specific actions of the peptide.
1 / 1 hearts (Fig. 3) . These cardiac contractile responses To elucidate whether the biphasic action of CNP is started immediately after addition of 8-pCPT-cGMP and mediated by activation of the NPR-C receptor, the specific peaked at 10 min. Coronary flow was significantly in-NPR-C ligand cANP [19] , was tested on GC-A 2 / 2 creased to 12465 (1 / 1) and 12063% (GC-A 2 / 2) (4 -23) hearts. cANP did not significantly alter either cardiac (*P,0.05 versus baseline). No significant changes in heart (4 -23) function or coronary flow (Table 2 ). In contrast to CNP, rate were observed. ANP at concentrations up to 100 nM had no effect on 8-pCPT-cGMP mimicked the later phase of the CNP contractility or relaxation of GC-A 1 / 1 (Table 2) or response, as observed in two experiments in which 8-GC-A 2 / 2 hearts (data not shown).
pCPT-cGMP was continuously infused into GC-A 2 / 2 hearts for 60 min. The initial increase in inotropy was 3.3. Characterization of the 'acute' effects of CNP on followed by a slowly developing decrease in both left cardiac contractility ventricular pressure and maximal rate of contraction to values which were, respectively, 863% and 1062% lower To further characterize the immediate contractile rethan baseline at 60 min. The positive lusitropic effect sponses to CNP, in an additional series of experiments (increased maximal rate of relaxation and decreased time CNP (1, 10 and 100 nM) was infused into isolated working of relaxation) remained stable over 30 min and then slowly hearts for 5 min. Each concentration was tested in a returned to baseline after 60 min of continuous 8-pCPTseparate group of hearts. As shown in Fig. 2, lower cGMP infusion. No significant changes in heart rate were concentrations of CNP (#10 nM) did not elicit any observed; coronary flow progressively increased to positive inotropic effect in GC-A 1 / 1 and 2 / 2 hearts.¯14068% of pretreatment values within 40 min, then The positive lusitropic effect was observed at a lower CNP remained stable for the remaining infusion time (*P,0.05 concentration in GC-A 2 / 2 hearts (10 nM) as compared vs. baseline). to GC-A 1 / 1 hearts (100 nM CNP).
Next we demonstrated that the enhanced responsiveness 3.5. Effects of ANP and CNP on cardiac cyclic of GC-A 2 / 2 hearts to CNP cannot be mimicked by nucleotide content 'acute' blockade of GC-A in GC-A 1 / 1 hearts. The ANP antagonist A71915 [20] , did not exert any intrinsic activity
In order to elucidate the molecular mechanisms mediat- Table 2 Effects of agents on left ventricular systolic pressure (LVP , in mmHg), maximal rates of contraction ( 1 dP/dt, mmHg / s) and relaxation ( 2 dP/dt, max mmHg / s), heart rate (HR, bpm), time to relaxation (in ms) and coronary flow (CF, ml / min / g) of isolated working hearts The NPR-C specific ligand, cANP (100 nM), was infused into GC-A 2 / 2 hearts for 30 min (n54); ANP (100 nM) was infused into GC-A 1 / 1 (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) hearts for 30 min (n56); the GC-A antagonist, A71915 (300 nM), or vehicle (KH) was infused into GC-A 1 / 1 hearts for 15 min followed by CNP (100 nM) for an additional 5 min (n55). Data are expressed as % of baseline (means6S.E.M.). *P,0.05 vs. baseline. ing the effect of CNP on cardiac contractile function, we GC-A 1 / 1 and GC-A 2 / 2 hearts perfused with KHstudied the cyclic nucleotide content of ventricular buffer (vehicle controls); 0.0360.01 vs. 0.0260.2 fmol / mg homogenates obtained from the isolated working heart protein (1 / 1 vs. 2 / 2, 5 min KH-infusion); 0.1260.05 preparations subjected to the experimental protocols vs. 0.0960.02 fmol / mg protein (1 / 1 vs. 2 / 2, 60 min studied above. Similar cGMP levels were detected in KH-infusion). ANP evoked a rather small, 2.560.3-fold increase in cGMP content of GC-A 1 / 1 hearts and this effect was completely absent in GC-A 2 / 2 hearts. Infusion of CNP induced marked increases of cGMP levels in both, GC-A 1 / 1 and GC-A 2 / 2 hearts (Fig. 4) . The absolute cGMP levels measured after infusion of CNP for 5 min (10 and 100 nM CNP) or 60 min (100 nM CNP) were not significantly different between GC-A 1 / 1 and GC-A 2 / 2 hearts (Fig. 4) . Also, the cGMP responses of GC-A 1 / 1 hearts to CNP were not different in the presence or absence of the GC-A antagonist, A71915 (not shown). Similar cAMP levels were detected in GC-A 1 / 1 and GC-A 2 / 2 hearts perfused with KH-buffer (controls); 1.5660.33 vs. 1.5560.4 fmol / mg protein (1 / 1 vs. 2 / 2 ent from these controls. Finally, the cAMP and cGMP contents of GC-A 2 / 2 hearts treated with the selective 3.7. Expression of cAMP-and cGMP-dependent protein NPR-C ligand, cANP , also were not significantly kinases (4 -23) different from KH-perfused controls. These observations rule out the possibility that activation of NPR-C or In order to study potential intracellular targets of the modulation of cardiac cAMP levels mediate the cardiac CNP/ GC-B system, the cardiac expression of cGMP-decontractile responses to CNP. pendent protein kinase (cGK I) was studied by Western blot analysis. As shown in Fig. 6 , cGK I expression was significantly increased in the ventricles from GC-A 2 / 2 3.6. Expression of GC-B and NPR-C mRNA as compared to GC-A 1 / 1 hearts by¯5364%. The expression of the cAMP-dependent protein kinase (cAK) C To determine whether long-term absence of GC-A and subunit was not different between GC-A 1 / 1 and 2 / 2 subsequent abolition of the action of ANP modifies the hearts (Fig. 6 ). Infusion of CNP (100 nM, 60 min) did not expression of receptors for CNP, the cardiac mRNA affect ventricular cGK I expression levels (data not expression of GC-B and NPR-C in control (KH-perfused) shown). hearts was quantitated by real-time RT-PCR. As shown, the mRNA expression levels of GC-B and NPR-C were 3.8. Expression and phosphorylation of phospholamban not significantly different in GC-A 2 / 2 versus GC-A 1 / 1 hearts (Fig. 5) .
To further investigate the mechanism of the inotropic and lusitropic effects of CNP, the expression and phosphorylation of the regulatory protein PLB were quantified by Western blot analysis. The expression levels of total PLB were not different in GC-A 2 / 2 as compared to 1 / 1 ventricles (Fig. 7, top) . The phosphorylation-specific antibody detected almost no signal in the ventricles of vehicle-treated (control) hearts (Fig. 7, top) . In contrast, a strong and concentration-dependent increase in PLB-PS-16 was detected in hearts treated with 10 and 100 nM CNP for 5 min (Fig. 7) . After CNP infusion for 5 min, phosphorylation at Ser , normalized to total PLB protein 16 content, was significantly increased by both 10 nM and 100 nM in GC-A 2 / 2 compared to GC-A 1 / 1 ventricles (Fig. 7, bottom) . Thus, the phosphorylation of PLB at Ser was increased by CNP and this effect was sig- 16 nificantly enhanced in the GC-A 2 / 2 hearts. The levels of phosphorylated PLB in GC-A 1 / 1 and GC-A 2 / 2 The expression levels of total PLB were not significantly C-subunit of cAK (40 kDa) were detected using specific antisera and a different between 1 / 1 and 2 / 2 ventricles. Bottom, the signal obtained peroxidase-labeled anti-rabbit antibody in an ECL detection system. cGK with the phosphorylation site specific antibody (PLB-PS-16) was normal-I expression was significantly upregulated in GC-A 2 / 2 compared to ized to the expression of total PLB. In control hearts perfused with § 1 / 1 ventricles (mean6S.E.M., n510, P,0.01). vehicle for the same period of time, the signal for PLB-PS-16 was almost undetectable. CNP evoked a concentration-dependent increase in PLB phosphorylation and this effect was significantly greater in GC-A 2 / 2 § ventricles (mean6S.E.M., n55-7, *P,0.05 vs. vehicle controls, P, for only 5 min (above). The effects of CNP on PLB 0.05 vs. GC-A 1 / 1).
phosphorylation were mimicked by 8-pCPT-cGMP. After infusion of GC-A 2 / 2 hearts with 100 mM 8-pCPTcGMP for 60 min, phosphorylation at Ser , normalized to effect on cardiac function, but deletion of GC-A, a receptor 16 total PLB protein content, was 1964.1 compared to for ANP, increases the cardiac responsiveness to CNP. 1462.2 at 60 min of CNP infusion (in arbitrary units).
Our observations regarding the cardiac contractile effects of CNP are corroborated by published studies in isolated dog and rat heart preparations. CNP evoked a marked immediate increase in the contractile force of 4. Discussion isolated canine atrial and ventricular preparations [12, 13] . In these studies, only immediate effects of CNP were The original findings of the present study are, firstly, evaluated. Extending these observations, a more recent that CNP exerts a biphasic effect on the performance of study in isolated rat papillary muscle demonstrated sequenisolated mouse working hearts: an immediate increase in tial actions of CNP on cardiac contractility, with an lusitropy, accompanied by a transient weak positive inoimmediate positive lusitropic and a slowly developing tropic action, followed by a slowly developing decrease in negative inotropic effect [14] . The time course of these inotropy. These effects on cardiac contractility are accomeffects was nearly identical to that observed in our panied by a stable increase in coronary flow. Secondly, the experiments. In both the previous [13, 14] as well as immediate lusitropic effects of CNP correlate with activapresent studies, ANP had no effect on any contractile tion of a cGMP-dependent pathway involving cGK I and parameter. phospholamban phosphorylation. Thirdly, ANP has no To further investigate the mechanisms mediating the
